Skip to content
healthcare.dev
Get a free key

Kanjinti

NDC 55513-132, trastuzumab-anns, injection, powder, lyophilized, for solution, from Amgen, Inc.

Product NDC
55513-132
Status
Listed
Labeler
Amgen, Inc
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761073
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRASTUZUMAB420 mg/20mL

Pharmacologic classes

HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]

Package NDCNDC-11Package
55513-132-01555130132011 VIAL, MULTI-DOSE in 1 CARTON (55513-132-01) / 20 mL in 1 VIAL, MULTI-DOSE
55513-132-21555130132211 VIAL, MULTI-DOSE in 1 CARTON (55513-132-21) / 20 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9a94f5b2-b84e-4987-8ea1-c4346db5a5fa

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55513-132

Use it

Look up 55513-132 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.